Charles River Laboratories | CRL - Ebitda

Prix De L'Action
150.85
Variation Quotidienne
-8.27 -5.20%
Mensuellement
-14.75%
Annuel
7.01%
Q2 Prévisions
147.82




Ebitda Changement Date
Agilent USD 540M 74M 2025-09
Align Technology USD 260.87M 77.03M 2025-12
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Bruker USD 110M 101.6M 2026-03
Cardinal Health USD 1.09B 109M 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Cigna USD 2.86B 56M 2025-03
CVS Health USD 5.83B 2.08B 2026-03
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 129M 6M 2026-03
Elevance Health USD 4.21B 2.02B 2026-03
Humana USD 2.06B 2.35B 2026-03
Illumina USD 469M 137M 2025-12
Incyte USD 367.97M 46.53M 2026-03
Intrexon USD -24.7M 2.92M 2024-06
IQVIA Holdings USD 932M 114M 2026-03
Laboratory Of America USD 605.6M 17.5M 2026-03
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
McKesson USD 1.88B 206M 2025-12
Merck EUR 1.44B 263M 2025-12
Mettler Toledo International USD 278.99M 100.24M 2026-03
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Quest Diagnostics USD 557M 20M 2026-03
Revvity USD 272.91M 24M 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
United Therapeutics USD 379.5M 83.4M 2025-12
UnitedHealth USD 9.99B 8.5B 2026-03
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03